Quarterly report pursuant to Section 13 or 15(d)

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)

v3.24.3
ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
ACCOUNTS PAYABLE AND ACCRUED EXPENSES    
Accrued research and development $ 2,968,508 $ 2,263,934
Accrued compensation expenses 247,210 716,307
Accrued professional fees 83,950 58,388
Other accounts payable and accrued expenses 19,097 3,809
Total $ 3,318,765 $ 3,042,438